How AP-2α Gene Loss Affects Melanoma
Author Information
Author(s): Karjalainen J M, Kellokoski J K, Mannermaa A J, Kujala H E, Moisio K I, Mitchell P J, Eskelinen M J, Alhava E M, Kosma V M
Primary Institution: University of Kuopio and Kuopio University Hospital, Kuopio, Finland
Hypothesis
The study investigates the mechanisms behind the down-regulation of the AP-2α gene in cutaneous melanoma.
Conclusion
The study suggests that failure in post-transcriptional processing may inactivate the AP-2α gene in cutaneous melanoma.
Supporting Evidence
- The loss of AP-2α expression is linked to poor prognosis in melanoma.
- 64% of samples with negative AP-2α protein still expressed mRNA.
- 80% of informative mRNA- and protein-negative areas showed loss of heterozygosity.
Takeaway
Researchers looked at how a gene called AP-2α is turned off in skin cancer, finding that problems in processing its message might be a reason.
Methodology
The study compared AP-2α protein expression patterns with mRNA expression in primary melanoma samples using immunohistochemistry and in situ hybridization.
Limitations
The analysis could not completely verify the role of TFAP2A as a tumor suppressor gene.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website